Investigation Overview
September 23, 2016 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of Tobira Therapeutics Inc (NASDAQ:TBRA), was announced concerning whether the takeover of Tobira Therapeutics Inc by Allergan plc is unfair to NASDAQ:TBRA stockholders. The investigation by a law firm concerns whether certain officers and directors of Tobira Therapeutics...
You must register (for free) or login to view the entire investigation.